Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) Director Karen Mcginnis sold 6,050 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $8.01, for a total transaction of $48,460.50. Following the completion of the sale, the director directly owned 94,671 shares of the company’s stock, valued at $758,314.71. This trade represents a 6.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Alphatec Stock Up 1.8%
Alphatec stock traded up $0.15 during trading hours on Friday, hitting $8.28. The company had a trading volume of 1,766,641 shares, compared to its average volume of 3,228,264. The firm has a market capitalization of $1.27 billion, a P/E ratio of -10.10 and a beta of 0.88. The company has a debt-to-equity ratio of 40.35, a current ratio of 1.90 and a quick ratio of 1.12. The firm’s fifty day moving average is $9.18 and its 200-day moving average is $13.98. Alphatec Holdings, Inc. has a fifty-two week low of $6.82 and a fifty-two week high of $23.29.
Institutional Investors Weigh In On Alphatec
A number of hedge funds and other institutional investors have recently made changes to their positions in ATEC. Summit Securities Group LLC purchased a new stake in shares of Alphatec during the 1st quarter worth about $29,000. Aster Capital Management DIFC Ltd bought a new position in shares of Alphatec in the 3rd quarter valued at approximately $34,000. Osterweis Capital Management Inc. bought a new position in shares of Alphatec in the 2nd quarter valued at approximately $37,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Alphatec by 157.1% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,571 shares of the medical technology company’s stock valued at $54,000 after acquiring an additional 1,571 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. bought a new position in shares of Alphatec in the 3rd quarter valued at approximately $73,000. 66.35% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
View Our Latest Research Report on ATEC
About Alphatec
Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.
Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.
Read More
- Five stocks we like better than Alphatec
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.
